Figure 4
Figure 4. Event-free survival during 5 years of follow-up in patients with ALL, according to the duration of postinduction chemotherapy.

Event-free survival during 5 years of follow-up in patients with ALL, according to the duration of postinduction chemotherapy.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal